Completed × Erlotinib Hydrochloride × Gastrointestinal × Clear all Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
Phase 3 Completed
546 enrolled 29 charts
Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer
Phase 1 Completed
30 enrolled
Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer
Phase 1 Completed
14 enrolled
A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)
Phase 1 Completed
95 enrolled
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Phase 2 Completed
673 enrolled 22 charts
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver
Phase 1/2 Completed
25 enrolled 10 charts
Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy
Phase 2 Completed
45 enrolled 7 charts
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
Phase 2 Completed
46 enrolled 13 charts
Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy
Phase 2 Completed
29 enrolled
Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer
Phase 2 Completed
62 enrolled 8 charts
S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
Phase 1/2 Completed
134 enrolled 12 charts
Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia
Phase 2 Completed
38 enrolled 14 charts
GEM
Phase 2 Completed
120 enrolled
Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer
Phase 1 Completed
24 enrolled
Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Phase 2 Completed
20 enrolled 11 charts
MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer
Phase 1/2 Completed
81 enrolled 19 charts
Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Phase 2 Completed
46 enrolled 13 charts
ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA)
Phase 2 Completed
48 enrolled 11 charts
Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer
Phase 1 Completed
14 enrolled
Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer
Phase 3 Completed
569 enrolled
Pemetrexed and Erlotinib for Metastatic Colorectal Cancer
Phase 2 Completed
50 enrolled
Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Phase 2 Completed
123 enrolled 10 charts
Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer
Phase 2 Completed
28 enrolled 11 charts
An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
Completed
338 enrolled 18 charts
Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Phase 1 Completed
9 enrolled
Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer
Phase 1 Completed
15 enrolled
Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine
Phase 2 Completed
36 enrolled 10 charts
Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors
Phase 1 Completed
OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
Phase 3 Completed
569 enrolled
Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
Phase 2 Completed
30 enrolled 7 charts
Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
Phase 2 Completed
95 enrolled 12 charts
S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
Phase 2 Completed
37 enrolled
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Phase 1 Completed
28 enrolled
Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer
Phase 2 Completed
32 enrolled 12 charts
Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer
Phase 1/2 Completed
32 enrolled 14 charts
Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer
Phase 2 Completed
104 enrolled 10 charts
A Study of Erlotinib in Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer
Phase 3 Completed
80 enrolled 10 charts
Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer
Phase 1 Completed
27 enrolled 6 charts
TARGET
Phase 1/2 Completed
44 enrolled
Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer
Phase 1 Completed
17 enrolled
Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer
Phase 2 Completed
45 enrolled 8 charts
A Biomarker Identification Trial of Tarceva (Erlotinib) in Patients With Advanced Pancreatic Cancer
Phase 2 Completed
207 enrolled 12 charts
FAPEST
Phase 2 Completed
92 enrolled 11 charts
Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer
Phase 2 Completed
22 enrolled 13 charts
Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients
Phase 4 Completed
54 enrolled
DREAM
Phase 3 Completed
700 enrolled
Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery
Phase 3 Completed
820 enrolled
A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and Survival
Phase 2 Completed
153 enrolled 16 charts
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
Phase 1 Completed
43 enrolled
ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer
Phase 1 Completed
32 enrolled 13 charts